Anti-TNF immunogenicity in a Middle Eastern inflammatory bowel disease cohort: prevalence, predictors and context-specific drug level thresholds
Shaima Wasim Khan, Noorah Al Hosani, Thaer Khaleel Swaid, Mazin M Edan, Mohammed Nabil Quraishi · 2026
Read Anti-TNF immunogenicity in a Middle Eastern inflammatory bowel disease cohort: prevalence, predictors and context-specific drug level thresholds by Shaima Wasim Khan, Noorah Al Hosani, Thaer Khaleel Swaid, Mazin M Edan, Mohammed Nabil Quraishi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13311678.txt.
Description
Shaima Wasim Khan and co-authors give a 2026 cohort study on immune reactions against anti-TNF drugs in Middle Eastern patients with inflammatory bowel disease. Such reactions are a top reason these drugs stop working.
The study covered 314 treatment courses in 248 patients at a tertiary center in the United Arab Emirates. Antibodies against the drugs arose in 28.3 percent of courses over a median of two years in this cohort. Reaction-driven failure was the leading cause of stopping treatment. Drug level cutoffs that flag coming reactions were derived for both main drugs. Prior surgery was the strongest predictor of a reaction.
Catalog record
| CREATOR | Shaima Wasim Khan, Noorah Al Hosani, Thaer Khaleel Swaid, Mazin M Edan, Mohammed Nabil Quraishi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46122 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |